Business Context and Reporting Period
This Form 8-K Current Report was filed by Prestige Consumer Healthcare Inc. on December 2, 2019. The filing discloses the entry into a material definitive agreement regarding the issuance of senior notes by Prestige Brands, Inc., a wholly owned subsidiary of the Company.
Key Financial Metrics and Debt Structure
- Debt Issuance: $400.0 million aggregate principal amount of 5.125% senior notes due 2028.
- Interest Payments: Payable semi-annually on January 15 and July 15, commencing July 15, 2020.
- Maturity Date: January 15, 2028.
- Security Status: Senior unsecured obligations of Prestige Brands, Inc., guaranteed on an unsecured senior basis by the Company and certain domestic restricted subsidiaries.
- Offering Type: Private offering exempt from registration under Rule 144A and Regulation S.
Material Changes and Covenants
The issuance of the notes introduces new financial obligations and covenants that restrict the Company's and its subsidiaries' ability to:
- Incur, assume, or guarantee additional indebtedness.
- Pay dividends or redeem/repurchase capital stock.
- Make other restricted payments or incur liens.
- Redeem debt junior to the notes.
- Sell assets or enter into mergers, consolidations, or affiliate transactions.
These covenants are subject to specific exceptions and qualifications outlined in the Indenture.
Redemption, Change of Control, and Risks
- Redemption Options:
- After January 15, 2023: Redeemable at set prices plus accrued interest.
- Before January 15, 2023: Redeemable at 100% of principal plus a make-whole premium and accrued interest.
- Equity Proceeds: Up to 40% of the principal may be redeemed prior to January 15, 2023, using net proceeds from certain equity offerings.
- Change of Control: In the event of a Change of Control, the Company must offer to purchase the notes at 101% of the aggregate principal amount plus accrued interest.
- Events of Default: Include nonpayment of principal or interest, breach of covenants, defaults on other indebtedness, judgments against the Company, unenforceable guarantees, and bankruptcy or insolvency events.
Financial Performance: The filing text does not provide revenue, profit, cash flow, margin, or liquidity metrics for the reporting period.
Investor Verification Checklist
- Verify the full text of the Indenture (Exhibit 4.1) to understand specific covenant exceptions and qualifications.
- Confirm the use of proceeds from the $400.0 million note issuance, which is not detailed in this summary.
- Review the Company's current leverage ratios to assess the impact of the new debt on liquidity and solvency.
- Monitor compliance with the new restrictions on dividends, stock repurchases, and additional indebtedness.